3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Prostatic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Melanoma
2
Lung Neoplasms
2
Carcinoma, Intraductal, Noninfiltrating
2
Small Cell Lung Carcinoma
1
Sarcoma
1
Prostate Adenocarcinoma
1
Mesothelioma, Malignant
1
Lymphatic Metastasis
1
Carcinoma, Renal Cell
1
Carcinoma, Merkel Cell
1
Breast Carcinoma In Situ
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Doxorubicin
5
pazopanib
4
Ifosfamide
3
pembrolizumab
2
Sunitinib
2
Radiotherapy, Conformal
2
Radiotherapy
2
tremelimumab
1
temsirolimus
1
sintilimab
1
saracatinib
1
sapanisertib
1
romidepsin
1
olaratumab
1
liposomal doxorubicin
1
indolepropanol phosphate
1
eribulin
1
durvalumab
1
Watchful Waiting
1
Surgical Procedures, Operative
1
Sorafenib
1
Razoxane
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Polymerase Chain Reaction
1
Observation
1
Nivolumab
1
Neoadjuvant Therapy
1
Methotrexate
1
MLN 8237
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Histiocytoma, Malignant Fibrous
×
Radiation Dose Hypofractionation
×
Clear all
No trials found.